ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Retinal deposits,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2,1,Retinal deposits,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3,2,Retinal infiltrates,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
4,1,Blebitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
4,2,Retinoschisis,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6,1,Exposure to SARS-CoV-2,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
6,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6,3,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
6,4,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
6,5,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
7,1,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
8,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8,2,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
8,3,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
8,4,Retinal fovea disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
9,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
11,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
12,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
12,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
12,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
12,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
12,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
12,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
13,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
13,2,Retinal deposits,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
14,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
15,1,Amblyopia,Amblyopic vision impairment,Vision disorders,Eye,N
16,1,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
16,2,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
